Report Detail
Global Bioresorbable Medical Polymer Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4723164 |
- 21 July, 2026 |
- Global |
- 103 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Bioresorbable Medical Polymer market size was valued at US$ 1025 million in 2025 and is forecast to a readjusted size of US$ 1933 million by 2032 with a CAGR of 10.3% during review period.
Bioresorbable Medical Polymer refers to a class of biocompatible polymer materials designed to gradually degrade and be absorbed by the human body through natural metabolic processes after fulfilling their medical function, widely used in temporary implants, drug delivery systems, wound closure devices, tissue engineering scaffolds, orthopedic fixation products, cardiovascular devices, and regenerative medicine applications to eliminate the need for secondary surgical removal procedures.
The Bioresorbable Medical Polymer industry chain includes upstream suppliers of bio-based monomers, petrochemical intermediates, catalysts, specialty additives, medical-grade chemicals, and precision polymerization equipment, while midstream manufacturers focus on polymer synthesis, purification, compounding, extrusion, molding, sterilization, material modification, and regulatory validation to produce bioresorbable medical-grade polymers and related components, and downstream sectors include medical device manufacturers, pharmaceutical companies, hospitals, research institutes, orthopedic implant producers, cardiovascular device developers, tissue engineering enterprises, and regenerative medicine providers that utilize these polymers for implants, drug delivery systems, sutures, and biodegradable medical devices, with increasing demand supported by aging populations, minimally invasive procedures, and advanced biomaterials innovation worldwide.
Current projects under construction and planning within the Bioresorbable Medical Polymer market include biodegradable cardiovascular stent manufacturing facilities, advanced orthopedic implant production plants, regenerative medicine material research centers, pharmaceutical controlled-release polymer expansion projects, tissue engineering scaffold development programs, medical-grade polymer compounding facilities, and 3D-printed bioresorbable implant commercialization initiatives across North America, Europe, China, Japan, and South Korea, where rising demand for minimally invasive and biodegradable medical technologies is accelerating investment activity, while manufacturers and biotechnology companies are simultaneously expanding GMP cleanroom infrastructure, pilot-scale polymer synthesis capabilities, clinical testing partnerships, biomaterials R&D laboratories, and strategic collaborations with hospitals, medical device companies, and academic research institutions to strengthen technological competitiveness and regulatory approval capacity.
2025 Global Market Average Gross Profit Margin: 42%.
The Bioresorbable Medical Polymer market has experienced rapid expansion due to increasing demand for advanced biomaterials, minimally invasive treatment technologies, and biodegradable medical devices. The market is transitioning from conventional permanent implant materials toward temporary bioresorbable solutions capable of degrading safely within the human body after completing therapeutic functions. Growth is strongly supported by rising global healthcare expenditures, aging populations, increasing orthopedic and cardiovascular disease prevalence, and technological advances in regenerative medicine and tissue engineering. North America remains one of the largest and most technologically advanced markets because of strong medical device innovation capabilities, extensive clinical research activity, and favorable reimbursement systems. Europe maintains significant market share due to strict medical quality standards, advanced biomaterials research, and strong pharmaceutical and medical device industries. Asia-Pacific, particularly China, Japan, and South Korea, is emerging as a major growth region supported by expanding healthcare infrastructure, government support for biotechnology innovation, and increasing domestic medical device manufacturing capabilities.
Market opportunities are closely associated with the expansion of regenerative medicine, drug delivery technologies, tissue engineering, and personalized healthcare solutions. Increasing demand for biodegradable orthopedic fixation devices, cardiovascular stents, wound closure materials, and controlled drug release systems continues to create substantial growth potential. Technological advances in nanotechnology, bioactive polymers, and 3D bioprinting are also opening new application areas for bioresorbable materials. Pharmaceutical and biotechnology companies are increasingly investing in polymer-based drug delivery systems capable of improving therapeutic efficiency and reducing side effects. However, the market also faces several risks, including high research and development costs, strict regulatory approval requirements, long clinical validation cycles, and technical challenges related to degradation control and mechanical stability. Material biocompatibility issues, sterilization sensitivity, and variability in in vivo degradation behavior may affect product performance and commercialization timelines. In addition, intellectual property barriers and the need for extensive clinical evidence may limit market entry for smaller companies.
Future trends are expected to include wider adoption of fully biodegradable cardiovascular devices, smart drug delivery polymers, tissue regeneration scaffolds, and AI-assisted biomaterials design platforms. Sustainability considerations, precision medicine development, and increasing demand for less invasive medical treatments are expected to remain the primary long-term drivers shaping the global Bioresorbable Medical Polymer market.
This report is a detailed and comprehensive analysis for global Bioresorbable Medical Polymer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bioresorbable Medical Polymer market size and forecasts, in consumption value ($ Million), 2021-2032
Global Bioresorbable Medical Polymer market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Bioresorbable Medical Polymer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Bioresorbable Medical Polymer market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioresorbable Medical Polymer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioresorbable Medical Polymer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Corbion, DSM-Firmenich, Poly-Med, Ashland, Forécreu, Zeus Company LLC, REVA, DuPont, BMG Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Bioresorbable Medical Polymer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polycaprolactone (PCL)
Polylactic-co-Glycolic Acid (PLGA)
Others
Market segment by Manufacturing Technology Type
Injection Molded
Extruded
Others
Market segment by Source Material Type
Synthetic Bioresorbable
Natural Bioresorbable
Bio-Based Bioresorbable
Hybrid Composite Bioresorbable
Others
Market segment by Application
Orthopedic Implants
Cardiovascular Stents
Drug Delivery Systems
Surgical Sutures
Others
Market segment by players, this report covers
Evonik
Corbion
DSM-Firmenich
Poly-Med
Ashland
Forécreu
Zeus Company LLC
REVA
DuPont
BMG Inc
Geon Performance Solutions LLC
Bezwada Biomedical LLC
Mitsui Chemicals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bioresorbable Medical Polymer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bioresorbable Medical Polymer, with revenue, gross margin, and global market share of Bioresorbable Medical Polymer from 2021 to 2026.
Chapter 3, the Bioresorbable Medical Polymer competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Bioresorbable Medical Polymer market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bioresorbable Medical Polymer.
Chapter 13, to describe Bioresorbable Medical Polymer research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Bioresorbable Medical Polymer by Type
- 1.3.1 Overview: Global Bioresorbable Medical Polymer Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Bioresorbable Medical Polymer Consumption Value Market Share by Type in 2025
- 1.3.3 Polylactic Acid (PLA)
- 1.3.4 Polyglycolic Acid (PGA)
- 1.3.5 Polycaprolactone (PCL)
- 1.3.6 Polylactic-co-Glycolic Acid (PLGA)
- 1.3.7 Others
- 1.4 Classification of Bioresorbable Medical Polymer by Manufacturing Technology Type
- 1.4.1 Overview: Global Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Bioresorbable Medical Polymer Consumption Value Market Share by Manufacturing Technology Type in 2025
- 1.4.3 Injection Molded
- 1.4.4 Extruded
- 1.4.5 Others
- 1.5 Classification of Bioresorbable Medical Polymer by Source Material Type
- 1.5.1 Overview: Global Bioresorbable Medical Polymer Market Size by Source Material Type: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Bioresorbable Medical Polymer Consumption Value Market Share by Source Material Type in 2025
- 1.5.3 Synthetic Bioresorbable
- 1.5.4 Natural Bioresorbable
- 1.5.5 Bio-Based Bioresorbable
- 1.5.6 Hybrid Composite Bioresorbable
- 1.5.7 Others
- 1.6 Global Bioresorbable Medical Polymer Market by Application
- 1.6.1 Overview: Global Bioresorbable Medical Polymer Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Orthopedic Implants
- 1.6.3 Cardiovascular Stents
- 1.6.4 Drug Delivery Systems
- 1.6.5 Surgical Sutures
- 1.6.6 Others
- 1.7 Global Bioresorbable Medical Polymer Market Size & Forecast
- 1.8 Global Bioresorbable Medical Polymer Market Size and Forecast by Region
- 1.8.1 Global Bioresorbable Medical Polymer Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Bioresorbable Medical Polymer Market Size by Region, (2021-2032)
- 1.8.3 North America Bioresorbable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.4 Europe Bioresorbable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Bioresorbable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.6 South America Bioresorbable Medical Polymer Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Bioresorbable Medical Polymer Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Evonik
- 2.1.1 Evonik Details
- 2.1.2 Evonik Major Business
- 2.1.3 Evonik Bioresorbable Medical Polymer Product and Solutions
- 2.1.4 Evonik Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Evonik Recent Developments and Future Plans
- 2.2 Corbion
- 2.2.1 Corbion Details
- 2.2.2 Corbion Major Business
- 2.2.3 Corbion Bioresorbable Medical Polymer Product and Solutions
- 2.2.4 Corbion Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Corbion Recent Developments and Future Plans
- 2.3 DSM-Firmenich
- 2.3.1 DSM-Firmenich Details
- 2.3.2 DSM-Firmenich Major Business
- 2.3.3 DSM-Firmenich Bioresorbable Medical Polymer Product and Solutions
- 2.3.4 DSM-Firmenich Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 DSM-Firmenich Recent Developments and Future Plans
- 2.4 Poly-Med
- 2.4.1 Poly-Med Details
- 2.4.2 Poly-Med Major Business
- 2.4.3 Poly-Med Bioresorbable Medical Polymer Product and Solutions
- 2.4.4 Poly-Med Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Poly-Med Recent Developments and Future Plans
- 2.5 Ashland
- 2.5.1 Ashland Details
- 2.5.2 Ashland Major Business
- 2.5.3 Ashland Bioresorbable Medical Polymer Product and Solutions
- 2.5.4 Ashland Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ashland Recent Developments and Future Plans
- 2.6 Forécreu
- 2.6.1 Forécreu Details
- 2.6.2 Forécreu Major Business
- 2.6.3 Forécreu Bioresorbable Medical Polymer Product and Solutions
- 2.6.4 Forécreu Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Forécreu Recent Developments and Future Plans
- 2.7 Zeus Company LLC
- 2.7.1 Zeus Company LLC Details
- 2.7.2 Zeus Company LLC Major Business
- 2.7.3 Zeus Company LLC Bioresorbable Medical Polymer Product and Solutions
- 2.7.4 Zeus Company LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Zeus Company LLC Recent Developments and Future Plans
- 2.8 REVA
- 2.8.1 REVA Details
- 2.8.2 REVA Major Business
- 2.8.3 REVA Bioresorbable Medical Polymer Product and Solutions
- 2.8.4 REVA Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 REVA Recent Developments and Future Plans
- 2.9 DuPont
- 2.9.1 DuPont Details
- 2.9.2 DuPont Major Business
- 2.9.3 DuPont Bioresorbable Medical Polymer Product and Solutions
- 2.9.4 DuPont Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 DuPont Recent Developments and Future Plans
- 2.10 BMG Inc
- 2.10.1 BMG Inc Details
- 2.10.2 BMG Inc Major Business
- 2.10.3 BMG Inc Bioresorbable Medical Polymer Product and Solutions
- 2.10.4 BMG Inc Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 BMG Inc Recent Developments and Future Plans
- 2.11 Geon Performance Solutions LLC
- 2.11.1 Geon Performance Solutions LLC Details
- 2.11.2 Geon Performance Solutions LLC Major Business
- 2.11.3 Geon Performance Solutions LLC Bioresorbable Medical Polymer Product and Solutions
- 2.11.4 Geon Performance Solutions LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Geon Performance Solutions LLC Recent Developments and Future Plans
- 2.12 Bezwada Biomedical LLC
- 2.12.1 Bezwada Biomedical LLC Details
- 2.12.2 Bezwada Biomedical LLC Major Business
- 2.12.3 Bezwada Biomedical LLC Bioresorbable Medical Polymer Product and Solutions
- 2.12.4 Bezwada Biomedical LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Bezwada Biomedical LLC Recent Developments and Future Plans
- 2.13 Mitsui Chemicals
- 2.13.1 Mitsui Chemicals Details
- 2.13.2 Mitsui Chemicals Major Business
- 2.13.3 Mitsui Chemicals Bioresorbable Medical Polymer Product and Solutions
- 2.13.4 Mitsui Chemicals Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Mitsui Chemicals Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Bioresorbable Medical Polymer Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Bioresorbable Medical Polymer by Company Revenue
- 3.2.2 Top 3 Bioresorbable Medical Polymer Players Market Share in 2025
- 3.2.3 Top 6 Bioresorbable Medical Polymer Players Market Share in 2025
- 3.3 Bioresorbable Medical Polymer Market: Overall Company Footprint Analysis
- 3.3.1 Bioresorbable Medical Polymer Market: Region Footprint
- 3.3.2 Bioresorbable Medical Polymer Market: Company Product Type Footprint
- 3.3.3 Bioresorbable Medical Polymer Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Bioresorbable Medical Polymer Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Bioresorbable Medical Polymer Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Bioresorbable Medical Polymer Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Bioresorbable Medical Polymer Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Bioresorbable Medical Polymer Consumption Value by Type (2021-2032)
- 6.2 North America Bioresorbable Medical Polymer Market Size by Application (2021-2032)
- 6.3 North America Bioresorbable Medical Polymer Market Size by Country
- 6.3.1 North America Bioresorbable Medical Polymer Consumption Value by Country (2021-2032)
- 6.3.2 United States Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 6.3.3 Canada Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Bioresorbable Medical Polymer Consumption Value by Type (2021-2032)
- 7.2 Europe Bioresorbable Medical Polymer Consumption Value by Application (2021-2032)
- 7.3 Europe Bioresorbable Medical Polymer Market Size by Country
- 7.3.1 Europe Bioresorbable Medical Polymer Consumption Value by Country (2021-2032)
- 7.3.2 Germany Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.3 France Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.5 Russia Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 7.3.6 Italy Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Bioresorbable Medical Polymer Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Bioresorbable Medical Polymer Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Bioresorbable Medical Polymer Market Size by Region
- 8.3.1 Asia-Pacific Bioresorbable Medical Polymer Consumption Value by Region (2021-2032)
- 8.3.2 China Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.3 Japan Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.5 India Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 8.3.7 Australia Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Bioresorbable Medical Polymer Consumption Value by Type (2021-2032)
- 9.2 South America Bioresorbable Medical Polymer Consumption Value by Application (2021-2032)
- 9.3 South America Bioresorbable Medical Polymer Market Size by Country
- 9.3.1 South America Bioresorbable Medical Polymer Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Bioresorbable Medical Polymer Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Bioresorbable Medical Polymer Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Bioresorbable Medical Polymer Market Size by Country
- 10.3.1 Middle East & Africa Bioresorbable Medical Polymer Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
- 10.3.4 UAE Bioresorbable Medical Polymer Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Bioresorbable Medical Polymer Market Drivers
- 11.2 Bioresorbable Medical Polymer Market Restraints
- 11.3 Bioresorbable Medical Polymer Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Bioresorbable Medical Polymer Industry Chain
- 12.2 Bioresorbable Medical Polymer Upstream Analysis
- 12.3 Bioresorbable Medical Polymer Midstream Analysis
- 12.4 Bioresorbable Medical Polymer Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Bioresorbable Medical Polymer. Industry analysis & Market Report on Bioresorbable Medical Polymer is a syndicated market report, published as Global Bioresorbable Medical Polymer Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Bioresorbable Medical Polymer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
